TTRX Turn Therapeutics Inc. - Common Stock

NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗
$9.10
Price · Aug 24, 2026
Fundamentals as of Aug 12, 2026
52W Range
$3–$26
27% of range
Analyst Rating
BUY
8 analysts
Price Target
$26
+186% upside
P/E (TTM)
-75.8
ROE
-141.7%
Net Profit Margin
—

TTRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$9.10
Market Cap
$268M
P/E (TTM)
-75.8
EPS (TTM)
$-0.12
Revenue (TTM)
—
Div Yield
—
ROE
-141.7%
Debt/Equity
—
52W Range
$3 – $27

TTRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
EPS $-0.12
2-point trend, -71.4%
2024-12-31 → 2025-12-31
Free Cash Flow —
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
TTRX
Peer Median
P/E (TTM)
-75.8
44.2
P/B
57.2
3.5

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
TTRX
Peer Median
ROA
-45.0%
-39.4%
ROE
-141.7%
-64.1%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
TTRX
Peer Median
Current Ratio
0.9
6.5
Quick Ratio
0.7
—

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
TTRX
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
TTRX
Peer Median
EPS (Diluted)
2-point trend, -71.4%
$-0.12
—

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
TTRX
Peer Median

TTRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 8 analysts
  • Strong Buy 3 37.5%
  • Buy 4 50.0%
  • Hold 1 12.5%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

1 analysts · 2026-08-21
Median target $26.00 +185.8%
Mean target $26.00 +185.8%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.03%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-0.03 $-0.03 -0.00%
Dec. 31, 2025 $0.01 $-0.04 0.05%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
TTRX $116M -32.8 — — -141.7% —
NMRA $312M -1.2 — — -165.2% —
FULC $753M -9.6 2752.0% — -26.6% —
DERM — -16.4 10.2% -18.5% -44.7% —
SIGA $438M 19.1 -31.8% 24.6% 11.4% —
ANTX $31M -1.0 — — -57.7% —
ORMP $112M 1.9 -50.4% 3202.5% 37.0% 0.65%
LLY — 46.8 44.7% 31.7% 101.2% —

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 12
Annual Income Statement data for TTRX
Metric Trend 20252024
R&D Expense 2-point trend, +8.0% $265.6K $246.0K
SG&A Expense 2-point trend, +260.6% $6M $2M
Operating Expenses 2-point trend, +226.0% $6M $2M
Operating Income 2-point trend, -226.0% $-6M $-2M
Interest Income 2-point trend, +3.0% $29.6K $28.7K
Other Non-op $176.5K ·
Net Income 2-point trend, -80.6% $-3M $-2M
EPS (Basic) 2-point trend, -71.4% $-0.12 $-0.07
EPS (Diluted) 2-point trend, -71.4% $-0.12 $-0.07
Shares (Basic) 2-point trend, +4.0% 27,716,045 26,643,432
Shares (Diluted) 2-point trend, +4.0% 27,716,045 26,643,432
EBITDA $-6M ·
Balance Sheet 13
Annual Balance Sheet data for TTRX
Metric Trend 20252024
Cash & Equivalents 2-point trend, +708.3% $4M $498.3K
Prepaid Expense 2-point trend, -46.6% $120.3K $225.3K
Current Assets 2-point trend, +373.3% $5M $1M
Intangibles 2-point trend, +12.2% $922.2K $821.9K
Total Assets 2-point trend, +493.6% $12M $2M
Current Liabilities 2-point trend, +748.0% $6M $707.9K
Capital Leases 2-point trend, -57.6% $34.1K $80.4K
Total Liabilities 2-point trend, +235.8% $7M $2M
Common Stock 2-point trend, +9.6% $2.9K $2.7K
Retained Earnings 2-point trend, -16.6% $-22M $-19M
Stockholders' Equity 2-point trend, +2741.4% $5M $-177.4K
Liabilities + Equity 2-point trend, +493.6% $12M $2M
Shares Outstanding 2-point trend, +9.7% 29,445,183 26,845,690
Cash Flow 8
Annual Cash Flow data for TTRX
Metric Trend 20252024
D&A 2-point trend, +11.1% $52.7K $47.5K
Stock-based Comp 2-point trend, +18.8% $419.2K $352.8K
Amort. of Intangibles 2-point trend, +12.8% $53.0K $47.0K
Operating Cash Flow 2-point trend, -88.3% $-3M $-1M
Investing Cash Flow 2-point trend, -53.8% $-153.0K $-99.5K
Stock Issued 2-point trend, +500.4% $7M $1M
Net Stock Activity $7M ·
Financing Cash Flow 2-point trend, +500.4% $7M $1M
Profitability 2
Annual Profitability data for TTRX
Metric Trend 20252024
ROA -45.0% ·
ROE -141.7% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for TTRX
Metric Trend 20252024
Current Ratio 0.9 ·
Quick Ratio 0.7 ·
Per Share 4
Annual Per Share data for TTRX
Metric Trend 20252024
Book Value / Share $0.16 ·
Cash Flow / Share $-0.09 ·
Cash / Share $0.14 ·
EPS (TTM) $-0.12 ·
Valuation (TTM) 7
Annual Valuation (TTM) data for TTRX
Metric Trend 20252024
Net Income TTM $-3M ·
Market Cap $116M ·
P/E -32.8 ·
P/B 24.8 ·
P / Tangible Book 30.8 ·
P / Cash Flow -45.3 ·
Earnings Yield -3.0% ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-31
Net Income $-3M$-2M
Diluted EPS $-0.12$-0.07
Balance Sheet
2025-12-312024-12-31
Current Ratio 0.9—
Quick Ratio 0.7—

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 30 filers · $8.2M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
11 (+8 vs prior Q) 2 (-2 vs prior Q) 3 (0 vs prior Q) 2 (0 vs prior Q) +655K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
SteelPeak Wealth, LLC $1,821,029 249,456 22.08% Shares
IEQ CAPITAL, LLC $1,659,991 227,396 20.13% Shares
DDFG, Inc $787,154 107,829 9.55% Shares
VANGUARD CAPITAL MANAGEMENT LLC $542,397 74,301 6.58% Shares
Wellington Shields & Co., LLC $479,844 65,732 5.82% Shares
MILLENNIUM MANAGEMENT LLC $442,022 60,551 5.36% Shares
Bridgewater Advisors Inc. $241,562 27,326 2.93% Shares
Aaron Wealth Advisors LLC $237,717 32,564 2.88% Shares
Tamar Securities, LLC $219,000 30,000 2.66% Shares
ROYAL BANK OF CANADA $206,000 28,250 2.50% Shares
CITADEL ADVISORS LLC $188,880 25,874 2.29% Shares
BROWN BROTHERS HARRIMAN & CO $172,922 23,688 2.10% Shares
HighTower Advisors, LLC $143,693 19,684 1.74% Shares
RVW Wealth, LLC $131,400 18,000 1.59% Shares
GEODE CAPITAL MANAGEMENT, LLC $125,136 17,142 1.52% Shares
Jefferies Financial Group Inc. $118,990 16,300 1.44% Shares
Composition Wealth, LLC $116,800 16,000 1.42% Shares
McCarthy Asset Management, Inc. $109,631 15,018 1.33% Shares
BANK OF AMERICA CORP /DE/ $103,105 14,124 1.25% Shares
VANGUARD FIDUCIARY TRUST CO $91,104 12,480 1.10% Shares
LPL Financial LLC $75,190 10,300 0.91% Shares
Cannon Financial Strategists, Inc. $73,000 10,000 0.89% Shares
MORGAN STANLEY $73,000 10,000 0.89% Shares
VANGUARD GROUP INC $49,171 12,480 0.60% Shares
BlackRock, Inc. $17,221 2,359 0.21% Shares
Blue Trust, Inc. $8,191 1,122 0.10% Shares
WELLS FARGO & COMPANY/MN $7,300 1,000 0.09% Shares
UBS Group AG $3,146 431 0.04% Shares
Pflug Koory, LLC $1,241 170 0.02% Shares
Caitong International Asset Management Co., Ltd $226 31 0.00% Shares

Company insiders 7 insiders · 2 officers · 5 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Zuraiz Chaudhary Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer. April 1, 2026 A 12,500 5 0 $49,872
Neilesh Shailesh Ghodadra Chief Medical Officer Oct. 8, 2025 A 10,000 0 0 $0
Martin William Dewhurst Director June 4, 2026 A 21,882 0 0 $0
Kent Edward Kester Director June 4, 2026 A 10,000 0 0 $0
Andrew Gengos Director June 4, 2026 A 10,000 0 0 $0
Arthur F Golden Director June 4, 2026 A 360,602 3 0 $192,873
Abraham Chesed — Oct. 23, 2025 P 1,447,268 1 0 $65,716

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 2 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWC · iShares Trust 0.02% 38,157 SH Aug. 21, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 64,275 SH Aug. 19, 2026 Daily